SELIG CO-AUTHORS RESEARCH ON ADVERSE EVENTS ANTICIPATED TO OCCUR IN PATIENTS WITH LUNG CANCER
March 2020

SELIG JOINS WORKING GROUP TO AUTHOR PAPER ON EXPANDING ACCESS TO LUNG CANCER CLINICAL TRIALS
March 2020

SELIG CO-AUTHORS PAPER ON THE PROMISE OF IMMUNO-ONCOLOGY
May 2019

SELIG SERVES AS SCIENTIFIC WRITER ON FIRST-EVER STUDY TO ASSESS RISK TOLERANCE IN THE SMA PATIENT COMMUNITY
May 2019

SELIG SERVES AS PROJECT LEAD FOR FDA NATIONAL BRAIN TUMOR SOCIETY WORKSHOP
March 2019